Phase 4 Myeloma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You must be 18 years old or older.
• You must be able to understand and sign a consent form agreeing to take part.
• You must be willing and able to follow the study schedule and meet all study requirements.
• You must have been diagnosed with multiple myeloma, confirmed by a laboratory tissue test, before joining the trial.
• You must be considered suitable for a procedure to collect your own stem cells and then receive them back as a transplant, based on your hospital's guidelines.
• If you are a woman who could become pregnant, you must use effective birth control during treatment and for 8 days after your last dose of the study drug (motixafortide).

Who may not be able to join:

• You have previously had a stem cell transplant, either using your own cells or cells from a donor.
• You have a blood condition called hemoglobin SS disease (sickle cell disease) or hemoglobin S trait that prevents you from safely receiving a drug called G-CSF.
• You have a history of serious mental confusion or psychiatric episodes caused by steroids that needed medical treatment.
• You have type 1 or type 2 diabetes that is poorly managed or has unstable blood sugar levels, making it unsafe in the doctor's opinion to receive a steroid medication called dexamethasone as part of the treatment (confirm with trial site).
• You have previously had a serious whole-body reaction to the study drug motixafortide.

Important: Always verify eligibility with the trial site directly before applying.